Market Tracker

01/20 12:58pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.6605
Delayed Data
As of 12:43pm ET
 +0.0004 / +0.06%
Today’s Change
0.60
Today|||52-Week Range
3.50
-7.58%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.66
Today’s open0.66
Day’s range0.65 - 0.69
Volume303,960
Average volume (3 months)563,204
Market cap$4.4M
Dividend yield--
Data as of 12:43pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+73.42%
Earnings growth (this year)+43.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales558.44
Price/Book0.49

Competitors

 Today’s
change
Today’s
% change
CBMXCombiMatrix Corp-0.05-1.56%
IGCIndia Globalization ...-0.02-5.82%
XTNTXtant Medical Holdin...-0.06-11.78%
ROSGRosetta Genomics Ltd-0.01-1.00%
Data as of 12:57pm ET, 01/20/2017

Financials

Next reporting dateApril 5, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$34.0K
Annual profit (last year)-$10.2M
Net profit margin-30,067.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts